unknown
Stage
About
Imvaria develops AI-driven digital biomarker software-as-medical-device solutions to enable non-invasive, accurate diagnosis and prognosis of lung diseases such as idiopathic pulmonary fibrosis, helping clinicians make earlier and more precise clinical decisions.
Explore Imvaria's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.